The Biomarker Summit 2017 covers topics such as:
- Neurological Biomarkers
- CSF / Fluid-based Biomarker Approaches
- Imaging in CNS Drug Discovery and Development
- EEG and Other Functional Biomarkers
- Early Identification and Preclinical Disease Biomarkers
- Biomarker Development in Neuropsychiatric Disorders
- Oncology Biomarkers
- Cell Free DNA and Blood-Based Assays
- Circulating Tumor Cells and Cell-Based Assays
- Digital & Molecular Pathology
- Imaging Biomarkers in Oncology
- Applications of Mass Spectrometry Platforms
- Next Generation Sequencing in the Clinic
- General Session (All Tracks)
- Implementing Diagnostic Tests in a Hospital
- Point of Care Testing
- Panel Discussion: Investment Perspectives & Funding Opportunities
- Panel Discussion: Regulatory & Reimbursement Trends in Biomarker Development
- Panel Discussion: Companion Diagnostics Development & Partnering Strategies
- Inflammatory / Immunological Biomarkers
- Predictive Biomarkers of Slowly Progressive Diseases
- Predicting Progression & Therapeutic Response of Cardiovascular Disease
- Immunological Biomarkers in Cancer
- Biomarkers and Surrogate Endpoints for Clinical Trials in Inflammatory Diseases
- Biomarker Challenges in Rare Diseases
The Biomarker Summit 2017 brings together researchers, scientists, decision-makers and other players from the biomarkers industry.